Florkem

1 x 100 ml

Liquid for injection, solution

Active substance

Florfenicol : 300 mg/ml

ATC code

QJ01BA90 Florfenicol

QJ01BA Amphenicols

QJ01B Amphenicols

QJ01 Antibacterials for systemic use

QJ Antiinfectives for systemic use

Species

Cattle and pigs.

Indications

Cattle:

Treatment of respiratory tract infections due to Mannheimia haemolytica, Pasteurella multocida and Histophilus somni susceptible to florfenicol.

Pigs:

Treatment of acute outbreaks of swine respiratory disease caused by strains of Actinobacillus pleuropneumoniae and Pasteurella multocida susceptible to florfenicol.

Dose to be administered and administration route

Intramuscular use. The injection should be given in the neck.

Cattle :

20 mg florfenicol per kg bodyweight, i.e. 1 ml of solution per 15 kg bodyweight, twice 48 hours apart.

Pigs :

15 mg florfenicol per kg bodyweight, i.e. 1 ml of solution per 20 kg bodyweight, twice 48 hours apart.

The dose volume given at any one injection site should not exceed 10 ml in cattle and 3 ml in pigs.

To ensure a correct dosage body weight should be determined as accurately as possible to avoid underdosing.

It is recommended to treat animals in the early stages of disease and to evaluate the response to treatment within 48 hours after the second injection. If clinical signs of respiratory disease persist 48 hours after the last injection, treatment should be changed using another formulation or another antibiotic and continued until clinical signs have resolved.

Adverse reactions

Cattle:

Very rare

(< 1 animal / 10,000 animals treated, including isolated reports):

Reduced food intake^{^[1]}

Soft stool^{1,^[2]}

Injection site reaction^{2,^[3]} (e.g inflammation, lesion)

Pigs:

Common

(1 to 10 animals / 100 animals treated):

Anal and rectal disorder (e.g. erythema, oedema) ¹,

Diarrhoea^1,2

Very Rare

(< 1 animal / 10,000 animals treated, including isolated reports):

Injection site reaction^2,3 (e.g inflammation, lesion)

¹ May affect 50% of the animals and be observed for up to one week.

² Transient.

³ Disappear within 28 days.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.